Observes children and teens with very rare tumors across several countries
Follows children with rare tumors such as paraganglioma, melanoma and GIST over time.
Plain-language title generated from the registry record
Registry title: An International Study on Pediatric Patients With Rare Tumors.
Key facts
- Where
- Padova, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 18 years old?
Source: NCT07072143, who can take part
Where in Italy
- Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova]Padova, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Azienda Ospedaliera di Padova
- Trial code
- NCT07072143
- Record updated
- 18 July 2025
- Original description
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.Read full original descriptionShow less
The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
Inclusion: Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center; Written informed consent from the patient and/or the parent/legal guardian.
Exclusion: Absence of Written informed consent from the patient and/or the parent/legal guardian.